Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other solid neoplasm 1

Conditions

Testicular Germ Cell Tumor 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
sabarubicin × Genitourinary × Clear all
NCT00027781 2012-07-24

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003982 2012-07-11

MEN-10755 in Treating Patients With Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
30 enrolled
Genitourinary

Testicular Germ Cell Tumor, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡